Architecture de la Souveraineté Biologique : Rétro-ingénierie du Crack de la Longévité 2026

Résumé FRCe document, produit avec l’assistance de Gemini 3 Raisonnement, est publié sous licence Apache 2.0. Il constitue une publication défensive volontaire (antériorité) et entre de ce fait dans l’état de la technique au sens des législations applicables : art. L 611-11 CPI / art. 54(2) CBE. Le rapport détaille la rétro-ingénierie systémique du « Crack de la Longévité » de 2026, transformant les thérapies géniques coûteuses en protocoles « Low-Tech » souverains. Il catalogue 40 innovations de rupture, incluant la reprogrammation épigénétique par petites molécules , le nettoyage de l’entropie circulatoire par don de plasma , et des vecteurs de livraison optimisés par IA. Chaque proposition est décrite de manière opérationnelle (enabling), classée avec des codes IPC/CPC, et accompagnée d'une preuve d'horodatage. Ce corpus vise à garantir l’accessibilité universelle aux outils de régénération biologique face aux monopoles technologiques. Abstract EN This document, produced with the assistance of Gemini 3 Raisonnement, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent statutes: EPC Art. 54(2); French IPC Art. L 611-11; 35 U.S.C. §102(a); Chinese Patent Law Art. 22(5) (中华人民共和国专利法); and Japanese Patent Act Art. 29(1) (特許法). It details the systemic reverse-engineering of the 2026 "Longevity Crack," shifting high-cost gene therapies toward sovereign "Low-Tech" protocols. The report catalogs 40 breakthrough innovations, including small-molecule epigenetic reprogramming , circulatory entropy dilution via plasma donation , and AI-optimized delivery vectors. Every proposal is described in an enabling manner, classified with IPC and CPC codes, and accompanied by timestamp proof (RFC 3161 / FreeTSA). This work ensures universal access to biological regeneration tools against technological monopolies. Timestamp: 2026-03-01T21:37:59ZSHA-256: f9153f440ef2484ca7f030524e82660b89adefb902305b2d7b212ace35502c12 1. Cumulative Proteomic Dilution Protocol [IPC A61M 1/34 ; CPC A61M 1/36] 2. Chemical Reprogramming SMs Cocktail [IPC A61K 31/00 ; CPC A61P 43/00] 3. Pulse-Phase-Lock Temporal Scheduler [IPC G16H 20/10 ; CPC G16H 40/67] 4. High-dose TET Enzyme Activator [IPC A61K 31/375 ; CPC A61P 3/02] 5. Hepatic STAT3/EZH2 Mimetic System [IPC A61K 31/155 ; CPC A61P 1/16] 6. PBM-Lutein Neuroprotection Kit [IPC A61N 5/06 ; CPC A61N 2005/06] 7. Tissue Coherence (Ctiss) Compaction [IPC A61M 37/00 ; CPC A61Q 19/08] 8. Osteogenic Wnt/Lithium Formulation [IPC A61K 33/00 ; CPC A61P 19/10] 9. Sovereign Edge Health IoT Hub [IPC G06F 21/62 ; CPC G16H 10/60] 10. Post-Cycle RCQ-P Locking Complex [IPC A61K 36/00 ; CPC A61P 35/00] 11. AI-Engineered RetroSOX/RetroKLF Factors [IPC C07K 14/47 ; CPC C12N 15/85] 12. Pan-cerebral Dyno-ahq BBB Vectors [IPC C12N 15/86 ; CPC A61K 48/00] 13. Selective SASP Nanoporous Filter [IPC B01D 71/02 ; CPC A61M 1/34] 14. SSA-Thymosine α1 Reset Protocol [IPC A61K 38/00 ; CPC A61P 37/04] 15. Ovarian miR-17-5p Exosome Therapy [IPC A61K 35/54 ; CPC A61P 15/08] 16. TRDP Perturb-seq Discovery Platform [IPC C12Q 1/68 ; CPC G16B 25/00] 17. DASC Pulmonary Pod Transplantation [IPC A61K 35/42 ; CPC A61P 11/00] 18. VC6TF Rapid CiPSC Induction [IPC A61K 31/506 ; CPC C12N 5/06] 19. GNOME-based Biosensor Materials [IPC G01N 33/48 ; CPC H10N 30/00] 20. Youth Signal (Γplasma}) Algorithm [IPC G16H 50/30 ; CPC G16H 10/40] 21. MCCS Humoral Factory Reset [IPC A61M 1/36 ; CPC A61M 1/3693] 22. Biological Learning Coefficient (ηbio) [IPC G16B 40/00 ; CPC G16B 5/00] 23. Dyno-bn8 Cardiac/Muscle Vector [IPC C12N 15/86 ; CPC A61K 48/00] 24. Modular WMP MQTT Sovereign IoT [IPC G06F 21/62 ; CPC G16H 10/60] 25. Protein Syntax Logic Simulation [IPC G16H 50/50 ; CPC G16B 5/20] 26. Multi-Peptide-Silybin Matrix Stabilizer [IPC A61K 8/64 ; CPC A61Q 19/08] 27. Nutritional Thymic Reset Method [IPC A23L 33/00 ; CPC A61P 37/04] 28. Selective Protein Exclusion Kidney [IPC A61M 1/34 ; CPC A61M 1/3696] 29. Modular 12-Factor Safety Module [IPC C12N 5/06 ; CPC C12N 15/85] 30. Accelerated Material Engine (Dacc) [IPC G16C 60/00 ; CPC G06N 3/00] 31. Reduced Liver Toxicity Neuro-delivery [IPC C12N 15/86 ; CPC A61K 48/00] 32. Transcriptomic Cell Hashing Workflow [IPC C12Q 1/68 ; CPC G16B 25/00] 33. AF3 Transient State Capture [IPC G16C 20/30 ; CPC G16B 15/00] 34. Scell Thermodynamic Phase Modeling [IPC G16H 50/50 ; CPC G16B 5/20] 35. Automated Lab-Loop Lab-to-GPT [IPC G16B 30/00 ; CPC G16H 50/00] 36. ER-100 Retinal Methylation Reset [IPC A61K 48/00 ; CPC A61P 27/02] 37. SM-based STAT3 Phosphorylation Target [IPC A61K 31/00 ; CPC A61P 43/00] 38. SVCT2 Saturation Kinetic Delivery [IPC A61K 9/127 ; CPC A61K 31/375] 39. SIRT3 Mitochondrial Rescue Exosomes [IPC A61K 35/54 ; CPC A61P 15/08] 40. Biological Identity Quiddity Protection [IPC G06F 21/60 ; CPC G16H 10/00] Keywords Longevity Reverse Engineering, Epigenetic Reprogramming, Sovereign Biology, Pulse-Phase-Lock, Small Molecules Rejuvenation, Plasma Dilution Proxy, TET Enzyme Activation, Biological Sovereignty, Low-Tech Longevity, Edge Health Monitoring, RetroSOX, Dyno-ahq, Nanoporous Filtration, Thymic Reset, Ovarian Exosome, TRDP, DASC Alveolar Repair, VC6TF, GNOME, Youth Signal, MCCS, eta-bio, Dyno-bn8, MQTT, Cell Logic, HD Human, Nutritional Reset, Safety Module, Accelerated Discovery, Neuro-delivery, Cell Hashing, AF3 Binding, Scell Phase, ER-100, STAT3 Inhibition, SVCT2 Saturation, SIRT3 Rescue, Quiddity Protection, Biological OS, Cellular Stability.